Affordable Coding for Small Share Market Traders
Dr Reddy’s Laboratories Ltd.’s profit in the second quarter of this financial year rose 7.3% to Rs 1,347 crore, driven by momentum in branded markets and steady contributions from the Nicotine Replacement Therapy portfolio.
Laurus Labs Ltd. reported a significant surge in net profit for the second quarter, but its shares declined over 3%. What does this mean for investors and what are the key takeaways from the company’s Q2 performance?
Rubicon Research Ltd., backed by US private equity giant General Atlantic, is set to launch its Rs 1,377.5-crore initial public offering of shares. Here’s what Indian investors need to know.